Anticoagulation for the initial treatment of venous thromboembolism in people with cancer

BACKGROUND: Compared with people without cancer, people with cancer who receive anticoagulant treatment for venous thromboembolism (VTE) are more likely to develop recurrent VTE. OBJECTIVES: To compare the efficacy and safety of three types of parenteral anticoagulants (i.e. fixed‐dose low molecular...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Hakoum, Maram B, Kahale, Lara A, Tsolakian, Ibrahim G, Matar, Charbel F, Yosuico, Victor ED, Terrenato, Irene, Sperati, Francesca, Barba, Maddalena, Schünemann, Holger, Akl, Elie A
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2018
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6389339/
https://ncbi.nlm.nih.gov/pubmed/29363105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006649.pub7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller